CBMR publications and media appearances in May 2026
Every month we release a full list of publications from the Center, as well as media appearances by the Center scientists
Media Appearances
Professor Jens Juul Holst
Videnskab.dk, 13/05/2026
'Simpelt kosttilskud kan hjælpe med varigt vægttab: Et gennembrud, siger professor'
Jyllands-Posten, 17/05/2026 (in print only: section 1, page 24)
'Simpelt kosttilskud kan fastholde et vægttab'
Associate Professor Christoffer Clemmensen
Berlingske, 22/05/2026
'Nyt studie viser, at simpelt kosttilskud kan hjælpe med at holde vægttab: »Det er første gang, jeg ser noget så overbevisende«'
Publications
Arumugam & Hansen Groups
Jensen EL, et al. Paired Liver Biopsies vs Noninvasive Tests as Surrogate Endpoints for Clinical Trials in Metabolic and Alcohol-Related Liver Disease and Alcohol-Related Liver Disease. Clin Gastroenterol Hepatol. 2026 May 14:S1542-3565(26)00334-4. doi: 10.1016/j.cgh.2026.04.027. Epub ahead of print.
Clemmensen Group
Petersen J & Clemmensen C. Harnessing PPAR pharmacology through dual incretin- directed delivery. Cell Metab. 2026 Jun 2;38(6):1051-1053. doi: 10.1016/j.cmet.2026.04.009. Epub 2026 May 7.
Petersen J, et al. The evolving landscape of obesity pharmacotherapy. Nat Rev Drug Discov. 2026 Aug;25(8):619-647. doi: 10.1038/s41573-026-01427-1. Epub 2026 May 13.
Guasch Group
Mogna-Peláez P, et al. Planetary Health Diet Adherence Improves Weight and Body Composition During Energy Restriction. Obesity (Silver Spring). 2026 Jun;34(6):1265-1276. doi: 10.1002/oby.70215. Epub 2026 May 20.
Hansen Group
Frederiksen TC, et al. Interaction between clinical and genetic risk of atrial fibrillation in the danish diet, cancer and health cohort. Open Heart. 2026 May 20;13(1):e004078. doi: 10.1136/openhrt-2026-004078.
Razay J, et al. Associations Between Neuropathy, Nephropathy and Hearing Loss in Individuals with Type 2 Diabetes. Biomedicines. 2026 May 20;14(5):1153. doi: 10.3390/biomedicines14051153.
Juul Holst Group
Helsted MM, et al. Effects of a 6-week subcutaneous infusion of native GIP alone or as add-on to semaglutide in people with type 2 diabetes: a single-centre, double- blind, parallel-group, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2026 Jul;14(7):581-593. doi: 10.1016/S2213-8587(26)00075-6. Epub 2026 May 22.
Klausen MK, et al. Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial. Lancet. 2026 May 2;407(10540):1687-1698. doi: 10.1016/S0140-6736(26)00305-3.
Mount S, et al. Pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity: a controlled randomized trial. Nat Med. 2026 Jun;32(6):2107-2116. doi: 10.1038/s41591-026-04394-7. Epub 2026 May 13.
Olsson LM, et al. Gut microbiota responses to bariatric surgery are associated with metabolic outcomes and type 2 diabetes remission. Nat Metab. 2026 May;8(5):1212-1228. doi: 10.1038/s42255-026-01525-9. Epub 2026 May 7.
Sørum NE, et al. The Glucagonotropic Effect of GIP Is Negated During Insulin-Induced Hypoglycemia in Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study. Diabetes. 2026 Jul 1;75(7):1142-1149. doi: 10.2337/db25-1128.
Juul Holst & Pers Groups
Gæde J, et al. A randomised clinical trial testing the safety of and metabolic responses to short-term duodenal infusion of recombinant RORDEP1 in healthy men. Diabetologia. 2026 Aug;69(8):2338-2346. doi: 10.1007/s00125-026-06751-0. Epub 2026 May 23.
Kilpeläinen Group
Belanich JR & Kilpeläinen TO. Dual perspectives on human gene networks from gain- and loss-of-function interaction maps. Physiol Genomics. 2026 Jun 1;58(6):267-269. doi: 10.1152/physiolgenomics.00023.2026. Epub 2026 May 8.
Loos Group
Barnao KM, et al. Co-occurring clonal hematopoiesis exhibits strong selection and high leukemia risk. Nat Commun. 2026 May 21;17(1):6682. doi: 10.1038/s41467-026-73302-x.
Ockerman F, et al. An efficient LASSO framework for admixture-aware polygenic scores. HGG Adv. 2026 Jul 9;7(3):100628. doi: 10.1016/j.xhgg.2026.100628. Epub 2026 May 18.
Merino Group
Martin-Olmedo JJ, et al. Meal pattern matters: Associations of meal-specific dietary patterns with postprandial glucose response in free-living adults with obesity. Clin Nutr. 2026 Jun;61:106671. doi: 10.1016/j.clnu.2026.106671. Epub 2026 Apr 18.
Moritz Group & Metabolomics Platform
Anagho-Mattanovich M, et al. Protocol for integrating and interpreting multi-omics data combining unsupervised and supervised data integrating approaches. STAR Protoc. 2026 Jun 19;7(2):104534. doi: 10.1016/j.xpro.2026.104534. Epub 2026 Apr 30.
Rasmussen Group
Hu D, et al. Molecular maps of diseases from omics data and network embeddings. NPJ Syst Biol Appl. 2026 May 22. doi: 10.1038/s41540-026-00746-8. Epub ahead of print.
Treebak Group
Kuentzel KB, et al. Arachidonoyl-taurine is elevated in human MASLD and protects against hepatic steatosis and inflammation in preclinical models. J Hepatol. 2026 May 9:S0168-8278(26)00271-0. doi: 10.1016/j.jhep.2026.04.033. Epub ahead of print.
Treebak Group & Metabolomics Platform
Heaselgrave SR, et al. Glucocorticoid excess disrupts NAD+ homeostasis in male and female mice. J Endocrinol. 2026 May 22;269(2):e260011. doi: 10.1530/JOE-26-0011.